BeStock  
Markets › Compare › RXRX vs AGIO

RXRX vs AGIO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RXRX · Recursion Pharmaceuticals$2.45 ▼ 9.93%
AGIO · Agios Pharmaceuticals$27.60 ▼ 4.03%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5081111142173Nov 24, '25May 26, '26Nov 20, '26
  • RXRX -43.4%
  • AGIO +4.2%

Head to head

MetricRXRXAGIO
Price$2.45$27.60
Change today▼ 9.93%▼ 4.03%
Market cap$1.53B$1.65B
Return, 3 months-24.6%-15.4%
Return, year to date-40.1%+1.4%
Return, 1 year-41.2%+9.4%
P/E (TTM)––
P/B1.71.7
P/E percentile vs own 5y67th48th
Dividend yield––
Revenue growth (YoY, latest qtr)+262.3%+330.0%
Net profit growth (YoY)+26.6%+37.1%
Gross margin27.9%93.8%
Operating margin-738.7%-297.7%
Net margin-709.8%-264.8%
Return on equity-48.7%-32.9%
Analyst target vs. price+170.6%+65.9%
Analyst buy share50%67%
RSI (14)3135
30-day volatility103.2%86.1%
Max drawdown, 1 year-50.6%-50.9%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AGIO is the largest of the group by market value.
  • AGIO has returned the most over the past year.
  • AGIO is growing revenue fastest.
  • AGIO keeps the most profit per dollar of sales.
  • AGIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top